Ismail Sherazaan D, Sebaa Shorok, Abrahams Bianca, Nason Martha C, Mumby Mitchell J, Dikeakos Jimmy D, Joseph Sarah B, Moeser Matthew, Swanstrom Ronald, Garrett Nigel, Williamson Carolyn, Quinn Thomas C, Abrahams Melissa-Rose, Redd Andrew D
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
bioRxiv. 2024 Nov 3:2024.11.01.621615. doi: 10.1101/2024.11.01.621615.
HIV-1 Nef mediates immune evasion and viral pathogenesis in part through downregulation of cell surface cluster of differentiation 4 (CD4) and major histocompatibility complex class I (MHC-I) on infected cells. While Nef function of circulating viral populations found early in infection has been associated with reservoir size in early-treated cohorts, there is limited research on how its activity impacts reservoir size in people initiating treatment during chronic infection. In addition, there is little research on its role in persistence of viral variants during long-term antiretroviral therapy (ART). Phylogenetically distinct genes (n=82) with varying estimated times of reservoir entry were selected from viral outgrowth variants stimulated from the reservoir of South African women living with HIV who initiated ART during chronic infection (n=16). These genes were synthesized and used in a pseudovirus infection assay that measures CD4 and MHC-I downregulation via flow cytometry. Downregulation measures were compared to the size of the replication-competent viral reservoir (RC-VR), estimated by quantitative viral outgrowth assay (QVOA) at 5 years after treatment initiation, as well as proviral survival time. Maximum Nef-mediated MHC-I downregulation was significantly associated with RC-VR size (p=0.034), but this association was not observed for CD4 downregulation. Conversely, we did not find a consistent association between intraparticipant MHC-I or CD4 downregulation and the variant timing of entry into the reservoir. These data support a role for Nef-mediated MHC-I downregulation in determining RC-VR size, but more work is needed to determine Nef's role in the survival of individual viral variants over time.
HIV-1 Nef部分通过下调受感染细胞表面的分化簇4(CD4)和主要组织相容性复合体I类(MHC-I)来介导免疫逃逸和病毒发病机制。虽然在感染早期发现的循环病毒群体的Nef功能与早期治疗队列中的病毒储存库大小有关,但关于其活性如何影响慢性感染期间开始治疗的人群的病毒储存库大小的研究有限。此外,关于其在长期抗逆转录病毒疗法(ART)期间病毒变体持续存在中的作用的研究也很少。从慢性感染期间开始接受ART的南非HIV感染女性(n = 16)的病毒储存库中刺激产生的病毒生长变体中选择了82个系统发育上不同的基因,其估计的进入储存库时间各不相同。这些基因被合成并用于假病毒感染试验,该试验通过流式细胞术测量CD4和MHC-I的下调。将下调测量结果与治疗开始后5年通过定量病毒生长试验(QVOA)估计的有复制能力的病毒储存库(RC-VR)大小以及前病毒存活时间进行比较。Nef介导的最大MHC-I下调与RC-VR大小显著相关(p = 0.034),但未观察到CD4下调与RC-VR大小的这种关联。相反,我们没有发现参与者体内MHC-I或CD4下调与进入储存库的变体时间之间存在一致的关联。这些数据支持Nef介导的MHC-I下调在确定RC-VR大小中发挥作用,但需要更多的研究来确定Nef在个体病毒变体随时间存活中的作用。